Morgan Stanley Eye Point Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 745,395 shares of EYPT stock, worth $4.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

745,395

Previous 1,816,254 58.96%

Holding current value

$4.85 Million

Previous $14.5 Million 61.73%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$7.02 - $12.12 $7.52 Million - $13 Million	-1,070,859 Reduced 58.96%	745,395 $5.55 Million
Q3 2024 Nov 14, 2024	SELL	$7.58 - $10.54 $3.31 Million - $4.6 Million	-436,543 Reduced 19.38%	1,816,254 $14.5 Million
Q2 2024 Oct 17, 2024	BUY	$8.16 - $22.89 $7.43 Million - $20.8 Million	910,682 Added 67.85%	2,252,797 $19.6 Million
Q2 2024 Aug 14, 2024	BUY	$8.16 - $22.89 $7.43 Million - $20.8 Million	910,682 Added 67.85%	2,252,797 $19.6 Million
Q1 2024 Oct 17, 2024	SELL	$19.93 - $29.71 $18.1 Million - $27.1 Million	-910,682 Reduced 40.42%	1,342,115 $27.7 Million
Q1 2024 Aug 16, 2024	BUY	$19.93 - $29.71 $462,734 - $689,806	23,218 Added 1.76%	1,342,115 $27.7 Million
Q1 2024 May 15, 2024	BUY	$19.93 - $29.71 $462,734 - $689,806	23,218 Added 1.76%	1,342,115 $27.7 Million
Q4 2023 Aug 16, 2024	SELL	$5.71 - $24.13 $5.33 Million - $22.5 Million	-933,900 Reduced 41.46%	1,318,897 $30.5 Million
Q4 2023 Feb 13, 2024	BUY	$5.71 - $24.13 $6.75 Million - $28.5 Million	1,182,076 Added 863.96%	1,318,897 $30.5 Million
Q3 2023 Nov 15, 2023	BUY	$7.99 - $15.36 $394,682 - $758,737	49,397 Added 56.5%	136,821 $1.09 Million
Q2 2023 Aug 14, 2023	SELL	$3.03 - $9.0 $5,802 - $17,235	-1,915 Reduced 2.14%	87,424 $760,000
Q1 2023 May 15, 2023	BUY	$2.28 - $5.04 $147,867 - $326,864	64,854 Added 264.87%	89,339 $262,000
Q4 2022 Feb 14, 2023	BUY	$2.37 - $7.2 $34,227 - $103,982	14,442 Added 143.8%	24,485 $85,000
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.12 $11,609 - $18,548	-1,668 Reduced 14.24%	10,043 $79,000
Q2 2022 Oct 27, 2022	BUY	$7.25 - $12.71 $17,856 - $31,304	2,463 Added 26.63%	11,711 $91,000
Q2 2022 Aug 15, 2022	BUY	$7.25 - $12.71 $17,856 - $31,304	2,463 Added 26.63%	11,711 $91,000
Q1 2022 Oct 27, 2022	SELL	$8.67 - $14.11 $21,354 - $34,752	-2,463 Reduced 21.03%	9,248 $113,000
Q1 2022 May 13, 2022	SELL	$8.67 - $14.11 $92,292 - $150,200	-10,645 Reduced 53.51%	9,248 $113,000
Q4 2021 Feb 14, 2022	BUY	$10.18 - $18.4 $139,598 - $252,319	13,713 Added 221.89%	19,893 $243,000
Q3 2021 Nov 15, 2021	BUY	$7.51 - $11.72 $46,411 - $72,429	6,180 New	6,180 $64,000

Others Institutions Holding EYPT

# of Institutions

151

Shares Held

65.9M

Call Options Held

143K

Put Options Held

173K

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $221M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account